GENE ONLINE|News &
Opinion
Blog

Regulatory
Policy FDA
FDA to Support Development of Non-Opioid Painkillers
2022-02-11
Asia-Pacific Gene Therapy
Astellas Reveals Early Safety Data of Gene Therapy for Pompe Disease
2022-02-09
China Rare Disease
China’s CANbridge Reports Positive Phase 1 Data of Contender to AstraZeneca’s Complement Inhibitor
2022-02-08
Trials & Approvals Sanofi
Sanofi’ Enjaymo Wins FDA Approval for Rare Autoimmune Anemia
2022-02-07
Trials & Approvals Cancer
EC Approves New Indication for Teysuno to Address Hand-Foot Syndrome and Cardiotoxicity
2022-02-07
Trials & Approvals Dry Eye
First Generic for Dry-eye Gets U.S. FDA Nod
2022-02-04
Trials & Approvals COVID-19 Vaccine
It’s Official! Moderna’s COVID Vaccine Receives FDA Approval
2022-02-02
Trials & Approvals
Cartesian’s Off-the-shelf RNA Therapy for Myeloma Enters Clinical Trials
2022-01-27
Trials & Approvals COVID-19
Remdesivir Cleared for Treating Non-Hospitalized COVID-19 Patients
2022-01-24
Trials & Approvals Bristol Myers Squibb
Bristol-Myers Squibb’s Abecma Becomes First Approved CAR T-Cell Therapy for Multiple Myeloma in Japan
2022-01-24
Trials & Approvals Schizophrenia
FDA Approves Drug for Schizophrenia in Pediatric Patients
2022-01-10
Regulatory FDA
Applied Therapeutics’ Galactosemia Program Stumbles Again after FDA Requests for More Data
2022-01-04
China Hong Kong
CStone Wins Hong Kong Approval for Gastrointestinal Tumor Drug
2021-12-29
Trials & Approvals FDA
FDA Gives Emergency Approval to Merck’s COVID-19 Pill after Giving Similar Nod to Pfizer’s Tablets
2021-12-24
Trials & Approvals HIV
FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention
2021-12-22
1 … 24 25 26 27 28 … 53
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top